Inner Banner

International 2026

breadCrumb

Submitted by admin on Wed, 11/19/2025 - 21:12
Type
common
  1. Bhandare MS, Nandy K, Parray AM, Pawar A, Padhy A, Menon V, Chopde A, Chaudhari V, Shrikhande SV (2026). Interplay of Post-Pancreatectomy Acute Pancreatitis, Postoperative Pancreatic Fistula, and Mortality after Pancreatoduodenectomy: Insights from a Comprehensive Cohort Study of 1594 Patients and Development of Predictive Nomograms. Journal of the American College of Surgeons.

  2. Chilukuri S, Sundar SC, Subramani V, Arjunan M, Raveendran V, Kamath R, Meena L, Guruvaiah A, Phurailatpam R, Selvaraj R, Chaudhari L, Kumaar V, Jain N, Tiwari M, Halsana P, Sharma D, Maitre P, Murthy V (2026). Pre-PROTO-PRIME study: Stereotactic body proton therapy to the prostate and pelvic nodes for high-risk and node-positive prostate cancer — feasibility, acute toxicity and dosimetric insights. Clinical and Translational Radiation Oncology.56:101084.

  3. Dhar A, Siva S, Tan VS, Mahadevan A, Bruynzeel A, Tang C, Cury F, Corkum M, Ali M, Zaorsky NG, Cheung P, Hannan R, Hudes R, Morgan S, Lo S, Murthy V, Correa RJM, Swaminath A (2026). International Radiosurgery Oncology Consortium of the Kidney (IROCK) contouring guidelines for renal cell carcinoma treated with stereotactic ablative radiotherapy. International Journal of Radiation Oncology, Biology, Physics.

  4. Gohil D, Gandhi KA, Gupta SK, Gera P, Yadav S, Patwardhan R, Checker R, Sharma D, Khattry N, Sandur S, Gota V( 2026). Immunomodulation by juglone alleviates acute graft-versus-host disease without compromising the graft-versus-leukaemia activity in mice. British Journal of Pharmacology. 183(1):131-152.PMID: 38584000

  5. Gupta R, Fielder T, Bal M..........Chernock R...Kamboj M...Patil A...Rane S...etal. on the behalf of the HN-CLEAR steering committee and clinical advisory group (2026). International consensus recommendations and alignment of terminology for the histopathological diagnosis of extranodal extension in head and neck squamous cell carcinoma: an HN-CLEAR initiative. Lancet Oncology. 27(1):e33-e44.

  6. Gupta S, Nair N, Hawaldar RW, Joshi S, Gulia S, Shet T, Sarin R, Parmar V, Desai S, Ghosh J, Wadasadawala T, Vanmali V, Panhale T, Parab P, Patil A, Chitkara G, Rath S, Bajpai J, Pathak R, Popat P, Thakur M, Badwe RA (2026). Addition of Carboplatin to Sequential Taxane-Anthracycline Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Phase III Randomized Controlled Trial. Journal of Clinical Oncology. 44(1):9-19. PMID: 41115255

  7. Kumari A, Mal A, Thorat R, Saha P, Patel P, Valvi S, CM Krishna, De A, Bandyopadhyaya R (2026). Sustained and localized delivery of gemcitabine using chitosan-PVA-TPP polymeric implant enhances antitumor efficacy and delays surgical relapse in pancreatic cancer. Biomaterials Advances. 179: 214489. PMID: 40976113

  8. Kizhakethil RV, Varma AK, Bhogale OV, Joshi MA, Barage SH, Kumar AWS, Kamble SS (2026). Conformational dynamics and energetic perturbations in human β-spectrin-II mediated by calpain cleavage-related mutations: Insights from enhanced sampling simulations. Computational Biology and Chemistry.120(Pt 2):108759.PMID: 41192394.

  9. Karale B, Tambe M, Rajak J, D'Silva SZ (2026). Identification of the Novel HLA-B Allele, HLA-B*57:198, in an Individual From North India. HLA. 107(1):e70538

  10. Iengar P, Venkatraman P (2026). Using the reactome graph database to generate pathway fingerprints for cancer-related genes, and using the fingerprints to gain insights into cancer, comorbidity, and cancer gene networks. Computational Biology and Chemistry. 120 Part 1: 108686.PMID: 41252800

  11. Meher R, Maharana J, Kavvuri J, K Nirmal Kumar, Pradhan T, Kailaje V, Ingle A, Sen S, Barkume M, Patkar M, Vaibhaw A, Mir SA, Ghosh A, Kamte S, Kamal A, Kode J (2026). A Phenstatin-based indole-chalcone hybrid as novel anti-inflammatory agent targeting the NLRP3 Inflammasome: Leads from computational and preclinical studies. Bioorganic Chemistry.170:109429.

  12. Patwardhan R, Rizvi Z, Gota V, Checker R, Singh B, Maurya D, Pal D, Ramani N, Kumar BK, Purohit V, Mathapati BS, Mullick J, Ghanty T, Gupta S, Joshi M, Madki S, Awasthi A, Sandur S, Sharma D (2026). First-in-human clinical trial of high-dose sodium copper chlorophyllin: Pharmacology and efficacy as a dual immunomodulatory/antiviral agent. Phytomedicine. 150: 157689. PMID: 41453293

  13. Pradhan P, Chaudhary T, Mishra S, Konik P, Durinova E, Tuma R, De A, Sinha D (2026). MCJ modulates mitochondrial ETC flux to promote lipid metabolism-driven enhancement of cell proliferation and migration. Cell Death and Disease.

  14. Siddiqui A, Dhandapani H, Rather A, Ingle A, Sharma D, Tayalia P (2026). In situ programming of CAR-macrophages via a polyplex nanomaterial and STING activation for triple-negative breast cancer immunotherapy. Nanoscale.

  15. Sinha S, Ghosh Laskar S, Dhingra S, Kumar A, Mohanty S, Budrukkar A, Swain M, Bishnu PN, Joy I, Ali R, Kannan S, Mummudi N (2026). Avoiding adjuvant Prophylactic Neck irradiation in lateralized oral cavity cancer (APRON). Clinical Oncology. 49: 103980

  16. Subramani V, Chauhan, H, David S, Maitre P, Menon S, Joshi A, Misra A, Arora A, Pal M, Prakash G, Murthy V (2026). Efficacy and safety of adjuvant radiotherapy in primary resected adrenocortical carcinoma – A comparative study. Journal of UroOncology 1(1): 24-30.

  17. Mirgh S, Sood K, Punatar S, Gokarn A, Chichra A, Nayak L, Bain G, Bagal B, Khattry N (2025). MRD directed consolidation in multiple myeloma – Are we there yet? Clinical Lymphoma Myeloma and Leukemia.

  18. Shenoy V, Kannan S, Noronha V, Prabhash K, Ostwal V, Bhargava P, Pillai A, Shamseeya K, Shetake A, Dhekale R, Chitre A, Gota V, Mahajan S, Daptardar A, Sonkusare L, Deodhar J, Ansari N, Vagal M, Mahajan P, Nookala M, Banavali SD, Ramaswamy A (2026). Development of a new model for prediction of relevant treatment related adverse events in older individuals with gastrointestinal cancers. Journal of Geriatric Oncology. 17(2):102817.

  19. Sahu A, Mehta D, Dasgupta A, Dev I, Puranik A, Bhattacharya K, Sahay A, Sridhar E, Shetty P, Moiyadi A, Menon N, Chatterjee A, Gupta T (2026). Patterns of radiation-induced subependymal enhancement in patients with high-grade glioma. Neuroradiology Journal.

  20. George A, Nair S, Prabhash K, Thakur S, Gera P, Singh A, Chaturvedi P, Rane S, Pradhan T, Sen S, Barkume M, Shetty D, Chaubal K, Ghosh A, Kamte S, Kode J (2026). Generation and characterization of early stage oral cancer cell line of buccal mucosa of Indian origin. Human Cell. 39: 21.

  21. Vatsa P, Chaudhary B, Kamble A, Waghmare S, Sharma S, Mandoli A (2026).Disrupting microtubule dynamics to rewire apoptosis, differentiation, and EMT programs in oral squamous cell carcinoma through indenamine derivatives. Bioorganic & Medicinal Chemistry.132:118444

Category
International
Select Year
2026
order
8
Back to Top